Cargando…
Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin
In the present study, we investigated the anticancer effects of the mitochondrial inhibitors, metaiodobenzylguanidine (MIBG), metformin and phenformin. (131)I-MIBG has been used for scintigraphic detection and the targeted radiotherapy of neuroblastoma (NB), a pediatric malignancy. Non-radiolabeled...
Autores principales: | WANG, STEPHANIE S., HSIAO, RUTH, LIMPAR, MARIKO M., LOMAHAN, SARAH, TRAN, TUAN-ANH, MALONEY, NOLAN J., IKEGAKI, NAOHIKO, TANG, XAO X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868499/ https://www.ncbi.nlm.nih.gov/pubmed/24190252 http://dx.doi.org/10.3892/ijmm.2013.1545 |
Ejemplares similares
-
Aurora kinase A is a possible target of OSU-03012 to destabilize MYC family proteins
por: SILVA, ANDRES, et al.
Publicado: (2014) -
S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines
por: IKEGAKI, NAOHIKO, et al.
Publicado: (2013) -
A Comparative Study of the Lipophilicity of Metformin and Phenformin
por: Dołowy, Małgorzata, et al.
Publicado: (2021) -
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma
por: Tang, Xao X., et al.
Publicado: (2021) -
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
por: Tang, Xao X., et al.
Publicado: (2022)